Hydrolysed Collagen Tripeptides (CTPs) are minimal bioactive signal units - exemplified by Gly-Pro-Hyp that outperform generic collagen hydrolysates as they preserve sequence integrity, cell recognition, and downstream signaling.

Following oral intake, CTPs are absorbed intact via PEPT1, appear in plasma within 30-60 min, and reach dermal tissue where they engage fibroblast receptors (e.g., CD44, α2β1, DDR1/2) and activate TGF-β/Smad and MAPK/ERK pathways.

This drives a consistent signal → synthesis → remodeling cascade, upregulating type I collagen, elastin, and hyaluronic acid, with clinically relevant outcomes - skin hydration / elasticity gains and wrinkle-depth reduction - typically observed within 8-12 weeks at ~1,000-2,500 mg/day.

Performance is spec-dependent: high Gly-Pro-Hyp content (≥50%) and Pro + Hyp 25-30% correlate with superior pharmacokinetics and effect sizes, while undefined peptides or free amino acids lack targeted signaling and reproducibility.

In multi-ingredient systems, CTPs synergize with elastin peptides and hyaluronic acid rebuild the dermal tension-and-recoil network.

Collectively, Gly-Pro-Hyp - enriched CTPs constitute a precision nutricosmetic modality coupling rapid systemic delivery with receptor-mediated ECM regeneration for visible anti-aging benefits.